185 related articles for article (PubMed ID: 19035248)
41. Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas.
Murga Penas EM; Hinz K; Röser K; Copie-Bergman C; Wlodarska I; Marynen P; Hagemeijer A; Gaulard P; Löning T; Hossfeld DK; Dierlamm J
Leukemia; 2003 Nov; 17(11):2225-9. PubMed ID: 12931213
[TBL] [Abstract][Full Text] [Related]
42. cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas.
Hu S; Du MQ; Park SM; Alcivar A; Qu L; Gupta S; Tang J; Baens M; Ye H; Lee TH; Marynen P; Riley JL; Yang X
J Clin Invest; 2006 Jan; 116(1):174-81. PubMed ID: 16395405
[TBL] [Abstract][Full Text] [Related]
43. Update on MALT lymphomas.
Isaacson PG
Best Pract Res Clin Haematol; 2005 Mar; 18(1):57-68. PubMed ID: 15694184
[TBL] [Abstract][Full Text] [Related]
44. BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.
Achuthan R; Bell SM; Carr IM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
J Pathol; 2002 Jan; 196(1):59-66. PubMed ID: 11748643
[TBL] [Abstract][Full Text] [Related]
45. Significance of Bcl10 gene mutations in the clinical diagnosis of MALT-type ocular adnexal lymphoma in the Chinese population.
Zhu J; Wei RL; Pi YL; Guo Q
Genet Mol Res; 2013 Apr; 12(2):1194-204. PubMed ID: 23661444
[TBL] [Abstract][Full Text] [Related]
46. BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma.
Ye H; Dogan A; Karran L; Willis TG; Chen L; Wlodarska I; Dyer MJ; Isaacson PG; Du MQ
Am J Pathol; 2000 Oct; 157(4):1147-54. PubMed ID: 11021819
[TBL] [Abstract][Full Text] [Related]
47. T(14;18)(q32;q21) involving MALT1 and IGH genes in an extranodal diffuse large B-cell lymphoma.
Cook JR; Sherer M; Craig FE; Shekhter-Levin S; Swerdlow SH
Hum Pathol; 2003 Nov; 34(11):1212-5. PubMed ID: 14652825
[TBL] [Abstract][Full Text] [Related]
48. Characterization of chromosomal aberrations in thymic MALT lymphoma.
Kominato S; Nakayama T; Sato F; Yamada S; Xia H; Fujiyoshi Y; Hattori H; Inagaki H
Pathol Int; 2012 Feb; 62(2):93-8. PubMed ID: 22243778
[TBL] [Abstract][Full Text] [Related]
49. MALT lymphoma: many roads lead to nuclear factor-κb activation.
Du MQ
Histopathology; 2011 Jan; 58(1):26-38. PubMed ID: 21261681
[TBL] [Abstract][Full Text] [Related]
50. FISH analysis of MALT lymphoma-specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma.
Schreuder MI; Hoefnagel JJ; Jansen PM; van Krieken JH; Willemze R; Hebeda KM
J Pathol; 2005 Feb; 205(3):302-10. PubMed ID: 15682432
[TBL] [Abstract][Full Text] [Related]
51. Nuclear factor kappaB activation and antiapoptosis in mucosa-associated lymphoid tissue lymphoma.
Hosokawa Y; Seto M
Int J Hematol; 2004 Oct; 80(3):215-23. PubMed ID: 15540895
[TBL] [Abstract][Full Text] [Related]
52. [Abnormal expression of bcl-10 protein in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue lymphoma type].
Li BZ; Zhou XY; Ye HT; Yang WT; Fan YZ; Lu HF; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):819-24. PubMed ID: 18346354
[TBL] [Abstract][Full Text] [Related]
53. The API2/MALT1 fusion product may lead to germinal center B cell lymphomas by suppression of apoptosis.
Stoffel A; Le Beau MM
Hum Hered; 2001; 51(1-2):1-7. PubMed ID: 11096264
[TBL] [Abstract][Full Text] [Related]
54. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
[TBL] [Abstract][Full Text] [Related]
55. Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment.
Rosebeck S; Lucas PC; McAllister-Lucas LM
Future Oncol; 2011 May; 7(5):613-7. PubMed ID: 21568677
[TBL] [Abstract][Full Text] [Related]
56. MALT lymphoma : recent advances in aetiology and molecular genetics.
Du MQ
J Clin Exp Hematop; 2007 Nov; 47(2):31-42. PubMed ID: 18040143
[TBL] [Abstract][Full Text] [Related]
57. BCL6 gene rearrangement and protein expression are associated with large cell presentation of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
Flossbach L; Antoneag E; Buck M; Siebert R; Mattfeldt T; Möller P; Barth TF
Int J Cancer; 2011 Jul; 129(1):70-7. PubMed ID: 20830719
[TBL] [Abstract][Full Text] [Related]
58. Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased VH4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment.
van Maldegem F; Wormhoudt TA; Mulder MM; Oud ME; Schilder-Tol E; Musler AR; Aten J; Saeed P; Kersten MJ; Pals ST; van Noesel CJ; Bende RJ
Leukemia; 2012 Jul; 26(7):1647-53. PubMed ID: 22382892
[TBL] [Abstract][Full Text] [Related]
59. Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma.
Grønbaek K; Ralfkiaer E; Kalla J; Skovgaard GL; Guldberg P
J Pathol; 2003 Sep; 201(1):134-40. PubMed ID: 12950026
[TBL] [Abstract][Full Text] [Related]
60. MALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast.
Talwalkar SS; Valbuena JR; Abruzzo LV; Admirand JH; Konoplev SN; Bueso-Ramos CE; Medeiros LJ
Mod Pathol; 2006 Nov; 19(11):1402-8. PubMed ID: 16917511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
